DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Maternal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Maternal Exposure During Pregnancy (66)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) where reactions include maternal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 66   Next >>

Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 36 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Epivir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-23

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21



Possible Reyataz side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-08

Patient: 30 year old female

Reactions: Stillbirth, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Epzicom
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-05-01

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-05-01

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-05-01



Possible Reyataz side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-08-08

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-07

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21



Possible Reyataz side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Mexico on 2012-07-23

Patient: 35 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Reyataz
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Reyataz side effects in 44 year old female

Reported by a physician from Thailand on 2012-07-16

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12



Possible Reyataz side effects in 22 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: 22 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Ritonavir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30

Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30



Possible Reyataz side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-03

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Reyataz
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14



Possible Reyataz side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: 28 year old female

Reactions: Vomiting, Nausea, Maternal Exposure During Pregnancy, Live Birth, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-04-18

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-01-01
    End date: 2011-04-18

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-04-18

Combivir
    Dosage: 2tab per day
    Indication: Antiviral Treatment
    Start date: 2011-01-01
    End date: 2011-04-18

Retrovir
    Indication: Antiretroviral Therapy
    Start date: 2011-09-11
    End date: 2011-09-11



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21



Possible Reyataz side effects in 31 year old female

Reported by a health professional (non-physician/pharmacist) from India on 2012-06-12

Patient: 31 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Stavudine
    Dosage: 60mgd per day
    Administration route: Oral
    Indication: HIV Infection

Reyataz
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: HIV Infection

Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: HIV Infection



Possible Reyataz side effects in 31 year old female

Reported by a physician from India on 2012-06-04

Patient: 31 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: HIV Infection

Reyataz
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: HIV Infection

Stavudine
    Dosage: 60mgd per day
    Administration route: Oral
    Indication: HIV Infection



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-01

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Kaletra

Omeprazole

Reyataz

Abacavir Sulfate / Lamivudine
    Dosage: 1 df, unk

Nevirapine

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 27 year old female

Reported by a physician from Japan on 2012-05-30

Patient: 27 year old female

Reactions: Anaemia, Alanine Aminotransferase Increased, Maternal Exposure During Pregnancy, Aspartate Aminotransferase Increased

Drug(s) suspected as cause:
Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-06

Retrovir
    Indication: Antiretroviral Therapy
    Start date: 2011-12-22

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-06

Truvada
    Indication: Antiretroviral Therapy
    Start date: 2012-02-28

Lamivudine (Epivir Hbv)
    Indication: Antiretroviral Therapy
    Start date: 2011-12-22

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22



Possible Reyataz side effects in 28 year old female

Reported by a physician from United States on 2012-05-25

Patient: 28 year old female

Reactions: Vomiting, Nausea, Maternal Exposure During Pregnancy, Live Birth, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Indication: Antiviral Treatment
    Start date: 2011-01-01
    End date: 2011-04-18

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-01-01
    End date: 2011-04-18

Reyataz
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-04-18

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-04-18

Retrovir
    Indication: Antiretroviral Therapy
    Start date: 2011-09-11
    End date: 2011-09-11



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-25

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy, Pregnancy

Drug(s) suspected as cause:
Omeprazole

Abacavir Sulfate and Lamivudine

Kaletra

Nevirapine

Reyataz

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 25 year old female

Reported by a physician from India on 2012-05-25

Patient: 25 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-01-11

Reyataz
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2012-01-11



Possible Reyataz side effects in 22 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 22 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30

Ritonavir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-30



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-23

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy, Drug Interaction

Drug(s) suspected as cause:
Nevirapine
    Indication: Product Used FOR Unknown Indication

Abacavir Sulfate / Lamivudine
    Indication: Product Used FOR Unknown Indication

Omeprazole

Omeprazole
    Indication: Product Used FOR Unknown Indication

Reyataz
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-22

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy, Pregnancy

Drug(s) suspected as cause:
Reyataz

Abacavir Sulfate / Lamivudine
    Dosage: 1 df= abacavir 600 mg + lamivudine 300 mg

Kaletra

Nevirapine
    Dosage: active substances: nevirapine

Omeprazole
    Dosage: active substances: omeprazole

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 36 year old female

Reported by a physician from United Kingdom on 2012-05-21

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Dosage: 600 mg / 300 mg

Omeprazole
    Administration route: Oral

Reyataz

Nevirapine

Kaletra

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-21

Patient: 42 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Raltegravir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-02-01

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2012-02-01

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01

Combivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-16

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Omeprazole

Kaletra

Abacavir Sulfate / Lamivudine
    Dosage: 1 df, unk

Reyataz

Nevirapine

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 36 year old female

Reported by a individual with unspecified qualification from United Kingdom on 2012-05-16

Patient: 36 year old female

Reactions: Viral Load Increased, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Nevirapine
    Indication: Product Used FOR Unknown Indication

Omeprazole
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: Product Used FOR Unknown Indication

Abacavir Sulfate and Lamivudine
    Dosage: 1 dosage forms
    Indication: Product Used FOR Unknown Indication

Reyataz
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Folic Acid



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 37 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy

Norvir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21



Possible Reyataz side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-04-17

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017